Atıf Formatları
Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. NAZIROĞLU Et Al. , "Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles," EXPERT REVIEW OF CLINICAL PHARMACOLOGY , vol.10, no.7, pp.773-782, 2017

NAZIROĞLU, M. Et Al. 2017. Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles. EXPERT REVIEW OF CLINICAL PHARMACOLOGY , vol.10, no.7 , 773-782.

NAZIROĞLU, M., MUHAMAD, S., & Pecze, L., (2017). Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles. EXPERT REVIEW OF CLINICAL PHARMACOLOGY , vol.10, no.7, 773-782.

NAZIROĞLU, Mustafa, Salina MUHAMAD, And Laszlo Pecze. "Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles," EXPERT REVIEW OF CLINICAL PHARMACOLOGY , vol.10, no.7, 773-782, 2017

NAZIROĞLU, Mustafa Et Al. "Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles." EXPERT REVIEW OF CLINICAL PHARMACOLOGY , vol.10, no.7, pp.773-782, 2017

NAZIROĞLU, M. MUHAMAD, S. And Pecze, L. (2017) . "Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles." EXPERT REVIEW OF CLINICAL PHARMACOLOGY , vol.10, no.7, pp.773-782.

@article{article, author={Mustafa NAZIROĞLU Et Al. }, title={Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles}, journal={EXPERT REVIEW OF CLINICAL PHARMACOLOGY}, year=2017, pages={773-782} }